In this edition of the Bottom Line blog, NCI Director Dr. W. Kimryn Rathmell discusses NCI’s fiscal year 2024 appropriation from Congress, which increases the base budget, but also reflects the end of dedicated funding for the Cancer Moonshot. The budget allows NCI to prioritize funding for new grants, particularly to early-stage investigators; training mechanisms; and Cancer Centers, while limiting the impact on continuing grants.